Biowarfare Research: Corporate America's Deadliest Secret

A number of major pharmaceutical corporations and biotech firms are concealing the nature of the biological warfare research work they are doing for the U.S. government. Since their funding comes from the National Institutes of Health, the recipients are obligated under NIH guidelines to make their activities public. Not disclosing their ops raises the suspicion they may be engaged in forbidden kinds of germ warfare research. In case you didn't know it, the White House since 9/11 has called for spending $44-billion on biological warfare research, a sum unprecedented in world history, and an obliging Congress has authorized it. Thus, some of the deadliest pathogens known to humankind are being rekindled in hundreds of labs in pharmaceutical houses, university biology departments, and on military bases. An international convention the U.S. signed forbids it to stockpile, manufacture or use biological weapons. But if the U.S. won't say what's going down in those laboratories other countries are going to assume the worst and a biowarfare arms race will be on, if it isn't already.